Omicron Variant, Black Friday News, Gazprom Record - What's Moving Markets

In This Article:

By Geoffrey Smith

Investing.com -- World markets recover a bit of poise after Friday's rout. Global health authorities warn that the new 'Omicron' variant of Covid-19 is potentially a high-risk development, but there is no evidence yet of it being more deadly than Delta. European gas prices continue to surge, as Gazprom (MCX:GAZP) reports record profits, and oil prices bounce on speculation that OPEC and its allies will pause their program of incremental output increases. Here's what you need to know in financial markets on Monday, 29th November.

1. Global markets retrace Omicron rout

Global markets recovered some – but by no means all – of their Friday losses as governments and health officials around the world stepped up their reaction to the discovery of the new Covid-19 variant, known as Omicron.

The dollar index, which tracks the greenback against a basket of developed market economies, stabilized after the initial shock of the news led traders to reprice the risk of interest rate hikes next year. By 6:35 AM ET (1135 GMT), it was up 0.1% at 96.165, still firmly within the upward trend that dates back to June. The yield on interest rate-sensitive two-year Treasury bonds was at 0.54%, up two basis points on the day but still down some 14 basis points from last week’s high.

European equity indices recovered about one-third of what they had lost on Friday, while emerging market currencies, oil and base metals also enjoyed recoveries of varying strength overnight.

2. WHO warns on Omicron but the verdict is far from clear

The Omicron variant was designated by the World Health Organization on Friday as a ‘variant of concern’, but the UN body stressed that there remains ‘substantial uncertainty’ over the dangers it poses. That uncertainty extends to how effective the current generation of vaccines will prove against it. Moderna (NASDAQ:MRNA) CEO Stephane Bancel and Pfizer (NYSE:PFE) CEO Albert Bourla have both expressed confidence that their vaccines can be adapted to fight the new variant within a couple of months.

Preliminary research findings in South Africa, where it was first identified, suggest it is sufficiently transmissible to ‘crowd out’ the Delta variant that has dominated this year’s waves of infection around the world. However, South African researchers have also said that it tended to trigger only mild infection (something that may not hold for the older populations of the northern hemisphere).

Various countries including the U.S. have now closed their borders to arrivals from South Africa and a handful of neighboring states. Japan and Israel have banned all foreign arrivals. However, there is already evidence of the variant as far afield as Canada, Australia and Europe.